AUS
NZ
UK
CA
USA
IND
Blue Star Helium Limited (ASX:BNL) announced that 145,378,405 unquoted Options expired unexercised on 30 June 2026, decreasing the total dilutive securities outstanding. These options, with an exercise price of $0.006 each and listed under the code BNLAJ, lapsed without conversion, resulting in no new ordinary shares issued and no cash inflow to the company. Following this expiry, Blue Star Helium holds 6,152,915,037 ordinary fully paid shares, along with other unquoted options and performance rights. Investors monitoring the company’s Capital Structure will note the reduced dilution potential, though short-term share price effects will depend on broader operational factors.
Key Points
- Company: Blue Star Helium Limited (ASX:BNL)
- 145,378,405 unquoted options (code: BNLAJ) expired unexercised on 30 June 2026
- Options had an exercise price of $0.006 each and were not converted into ordinary shares
- No consideration was paid by the company for the lapse
- Ordinary shares on issue after expiry: 6,152,915,037
- Remaining unquoted securities include 468,914,401 options expiring October 2026, 454,000,000 options expiring September 2027, 9,000,000 options expiring September 2027, and 122,200,000 performance rights
- Investors should monitor whether remaining options — especially the October 2026 Tranche — are exercised before expiry
Details Behind the Expiry of 145.4 Million BNLAJ Options Without Exercise
The BNLAJ options held by Blue Star Helium investors had an exercise price of $0.006 each and were set to expire on 30 June 2026. As unquoted instruments, these options were not traded on the ASX like ordinary shares. Holders needed to voluntarily exercise them by paying the $0.006 strike price per option before expiry.
The complete lapse of all 145,378,405 options in this tranche indicates no holders chose to convert them into ordinary shares before the deadline. Consequently, these options ceased to exist, reducing the outstanding BNLAJ options to zero. Blue Star Helium confirmed in its update that no payment was made for the lapse, consistent with ASX Listing Rules governing option expiries.
Implications of the Zero-Exercise Outcome on Blue Star Helium’s Fundraising Potential
When options expire unexercised, the company misses out on potential cash proceeds from their conversion. Had all 145,378,405 BNLAJ options been exercised at $0.006 each, Blue Star Helium could have raised approximately $872,000. This figure was not disclosed in the announcement, nor were any fundraising impacts addressed.
The lack of exercise may reflect market conditions near expiry, where BNL’s ordinary share price likely did not exceed the $0.006 strike price enough to incentivize conversion. However, the company did not comment on share price levels or holder decisions regarding this tranche, so any conclusions remain speculative.
Blue Star Helium’s Ordinary Share Count Now at 6.15 Billion After Option Expiry
Following the BNLAJ options lapse, Blue Star Helium’s Issued Capital stands at 6,152,915,037 fully paid ordinary shares traded under ticker BNL on the ASX. This figure represents the company’s fully diluted ordinary share count as of the cessation notice and is used by the ASX for calculating Market Capitalisation.
For a helium exploration firm with billions of shares outstanding, changes in capital structure can significantly influence per-share metrics. The expiry of roughly 145 million options, though small relative to total shares, reduces the maximum potential share count and slightly lowers dilution risk associated with the BNLAJ tranche.
Outstanding Unquoted Options and Their Terms
Despite the BNLAJ expiry, Blue Star Helium retains a large number of unquoted options still exercisable into ordinary shares. The largest remaining tranche is the BNLAG series, comprising 468,914,401 options at a $0.01 exercise price expiring on 30 October 2026. With this expiry only four months away from the update, investors will likely watch for any exercises ahead of that date.
Additional outstanding options include 454,000,000 BNLAH options exercisable at $0.01 expiring 25 September 2027, 9,000,000 BNLAF options with a $0.028 strike expiring 11 September 2027, plus 122,200,000 BNLAE performance rights. Full exercise of these securities would result in notable dilution and cash inflows, though the company did not comment on exercise probabilities.
Performance Rights Remain Part of Blue Star Helium’s Equity Incentives
The 122,200,000 BNLAE performance rights represent unquoted Equity instruments typically tied to specific operational, financial, or share price milestones. Unlike options, performance rights generally convert into shares upon meeting vesting conditions without requiring exercise payments.
Blue Star Helium did not disclose details about the vesting terms or expected near-term conversions of these performance rights in this update. Investors seeking clarity on their dilutive impact should consult prior disclosures such as the company’s latest Annual Report or remuneration report.
ASX Appendix 3H Filing Confirms Compliance and Disclosure of Option Expiry
The company’s announcement was submitted as an Appendix 3H — the ASX-mandated form for notifying security cessations. This filing is required promptly after securities such as options expire or are cancelled. Blue Star Helium lodged the form on 2 July 2026, one Business day after the 30 June 2026 expiry.
The Appendix 3H also includes a full update on issued capital across quoted and unquoted securities, ensuring transparency for investors, analysts, and market data providers. The company confirmed no consideration was paid for the lapse, consistent with standard practice when options expire.
Contextualising Blue Star Helium’s Capital Structure
Blue Star Helium is a helium exploration company with a capital structure featuring over six billion ordinary shares, reflecting typical equity financing for junior resource firms on the ASX. The company’s use of options provides holders with leveraged exposure to share price gains while offering Blue Star Helium potential cash inflows if exercised, without immediate capital raises.
The range of exercise prices from $0.006 to $0.028 suggests these options were issued at various times when the share price was near those levels. Whether remaining options are exercised depends on BNL’s share price relative to each Strike Price before expiry, which is influenced by progress in helium exploration and development. No operational updates were included in this filing.
Upcoming October 2026 Option Expiry Marks Next Capital Event
The next key date is 30 October 2026, when 468,914,401 BNLAG options at a $0.01 exercise price expire. This tranche is over three times larger than the recently expired BNLAJ series and will have a more significant impact on share count and potential cash inflows.
If fully exercised, Blue Star Helium would receive substantial proceeds and issue many new shares. Conversely, if these options lapse en masse, dilution pressure would ease without cash benefit, as with BNLAJ. The company has not provided guidance on expected exercise rates, so investors should monitor future updates and communications as the deadline approaches.
Share Price Impact and Investor Considerations
The expiry of 145,378,405 options is primarily a capital structure adjustment rather than an operational development, so immediate trading impacts are typically limited. No clear share price reaction was evident publicly. Fundamentally, removing this tranche of potential dilution is a modestly positive development for existing shareholders by lowering the maximum possible share count.
Prospective investors should consider the company’s remaining dilutive securities—over one billion options plus performance rights—alongside operational progress and cash position. The company did not disclose current cash or operational status in this update. For a comprehensive view of Blue Star Helium’s investment case, reviewing the latest quarterly activities report and other disclosures is recommended to understand exploration advances, funding needs, and management outlook.
